A magnetic resonance imaging study of the cerebellar vermis in chronically treated and treatment-naïve children with attention-deficit/hyperactivity disorder combined type.
BACKGROUND
Because of its dense connections to the prefrontal cortex and basal ganglia, the cerebellum is thought to play an important role in cognition. Numerous magnetic resonance imaging (MRI) studies have found abnormalities in the cerebellum in children with attention-deficit/hyperactivity disorder (ADHD). While some studies in animal and human models suggest that certain brain structures are affected by chronic stimulant medication, it is unclear whether the cerebellum is also affected. The purpose of the current study was to determine if cerebellar morphology was different in treatment-naïve versus chronically treated children with ADHD.


METHODS
There were 32 boys and 15 girls total (N = 47) that comprised three groups: ADHD-combined type (ADHD-C) children with no history of stimulant medication treatment (n = 14), ADHD-C children chronically treated with stimulant medication (n = 18), and typically developing control children (n = 15).


RESULTS
Treatment-naïve children with ADHD had significantly smaller area in the posterior inferior vermis (lobules VIII-X) than both chronically treated children with ADHD (p = .004) and typically developing control children (p = .001). No differences were observed between chronically treated children with ADHD and control children.


CONCLUSIONS
The results from this study suggest that chronic stimulant treatment may normalize the development of important areas of the cerebellar vermis in children with ADHD.
Bledsoe
Jesse
J
Department of Psychology, Michigan State University, East Lansing, MI 48823, USA.
Semrud-Clikeman
Margaret
M
Pliszka
Steven R
SR
D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy / Q000473:pathology*; D016022:Case-Control Studies; D000697:Central Nervous System Stimulants / Q000008:administration & dosage* / Q000494:pharmacology* / Q000627:therapeutic use; D002531:Cerebellum / Q000187:drug effects* / Q000473:pathology*; D002648:Child; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male
D000697:Central Nervous System Stimulants